Skip to main content

Table 1 Demographic details of both groups

From: Comparison of pretreatment with low-dose midazolam in combination with fentanyl and midazolam alone on the occurrence of etomidate-induced myoclonus—a randomized, double-blind study

 

Group MF*

(n=30)

Number (percentage)

Group M

(n=30)

Number (percentage)

P value

Age in years, mean±SD (angle)

3397 ± 13.4 (19–61)

41.6 ± 16.68 (18–75)

0.088

Age distribution in years

≤20

5 (16.67)

2 (6.67)

0.320

21–30

11 (36.67)

8 (26.67)

31–40

6 (20)

3 (10)

41–50

4 (13.33)

7 (23.33)

 

51–60

3 (10)

7 (23.33)

 

>60

1 (3.33)

3 (10)

 

Gender

Male

17 (56.67)

17 (56.67)

1.00

Female

13 (43.33)

13 (43.33)

ASA grade

I

15 (50)

19 (63.33)

0.297

II

15 (50)

11 (36.67)

Body weight in kg

Mean±SD (range)

62.13 ± 6.93 (48–73)

63.1 ± 8.1 (48–78)

0.603

  1. Chi-square test, Fisher’s exact test and Mann-Whitney U test were used to analyze the demographic parameters
  2. *MF Midazolam with Fentanyl, M Midazolam, SD Standard Deviation